These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 31515852)

  • 1. Chameleons and mimics: Progressive supranuclear palsy and corticobasal degeneration.
    Mimuro M; Yoshida M
    Neuropathology; 2020 Feb; 40(1):57-67. PubMed ID: 31515852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration.
    Koga S; Metrick MA; Golbe LI; Santambrogio A; Kim M; Soto-Beasley AI; Walton RL; Baker MC; De Castro CF; DeTure M; Russell D; Navia BA; Sandiego C; Ross OA; Vendruscolo M; Caughey B; Dickson DW
    Acta Neuropathol Commun; 2023 Jun; 11(1):88. PubMed ID: 37264457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case of Pathologically Confirmed Corticobasal Degeneration Initially Presenting as Progressive Supranuclear Palsy Syndrome.
    Chung EJ; Cho HJ; Jang W; Hur DY; Kim YS; Lee KH; Kim SJ
    J Korean Med Sci; 2022 Jun; 37(22):e183. PubMed ID: 35668689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration.
    Yoshida M
    Neuropathology; 2014 Dec; 34(6):555-70. PubMed ID: 25124031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticobasal degeneration: a disease with widespread appearance of abnormal tau and neurofibrillary tangles, and its relation to progressive supranuclear palsy.
    Mori H; Nishimura M; Namba Y; Oda M
    Acta Neuropathol; 1994; 88(2):113-21. PubMed ID: 7985491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological heterogeneity in progressive supranuclear palsy and corticobasal degeneration.
    Wakabayashi K; Takahashi H
    Neuropathology; 2004 Mar; 24(1):79-86. PubMed ID: 15068177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration.
    Dickson DW
    J Neurol; 1999 Sep; 246 Suppl 2():II6-15. PubMed ID: 10525997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A 65-year-old man with rigid-bradykinetic parkinsonism, vertical gaze palsy, difficulty of eye-lid opening, and marked pseudo-bulbar palsy].
    Noda K; Kobayashi T; Matsuoka S; Takanashi M; Kanazawa A; Mizuno Y
    No To Shinkei; 2005 Jan; 57(1):73-86. PubMed ID: 15782604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine learning-based decision tree classifier for the diagnosis of progressive supranuclear palsy and corticobasal degeneration.
    Koga S; Zhou X; Dickson DW
    Neuropathol Appl Neurobiol; 2021 Dec; 47(7):931-941. PubMed ID: 33763863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration.
    Briel N; Pratsch K; Roeber S; Arzberger T; Herms J
    Brain Pathol; 2021 Jul; 31(4):e12914. PubMed ID: 33089580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of astrocytic plaques in the corticobasal degeneration brain and comparison with tuft-shaped astrocytes in the progressive supranuclear palsy brain.
    Hattori M; Hashizume Y; Yoshida M; Iwasaki Y; Hishikawa N; Ueda R; Ojika K
    Acta Neuropathol; 2003 Aug; 106(2):143-9. PubMed ID: 12732936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
    Scaravilli T; Tolosa E; Ferrer I
    Mov Disord; 2005 Aug; 20 Suppl 12():S21-8. PubMed ID: 16092076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A proteomic study identifies different levels of light chain ferritin in corticobasal degeneration and progressive supranuclear palsy.
    Ebrahim AS; Kulathingal J; Murray ME; Casey-Castanedes M; Dickson DW; Yen SH; Sevlever D
    Acta Neuropathol; 2011 Dec; 122(6):727-36. PubMed ID: 22012136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substantia nigra in progressive supranuclear palsy, corticobasal degeneration, and parkinsonism-dementia complex of Guam: specific pathological features.
    Oyanagi K; Tsuchiya K; Yamazaki M; Ikeda K
    J Neuropathol Exp Neurol; 2001 Apr; 60(4):393-402. PubMed ID: 11305875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy.
    Katsuse O; Iseki E; Arai T; Akiyama H; Togo T; Uchikado H; Kato M; de Silva R; Lees A; Kosaka K
    Acta Neuropathol; 2003 Sep; 106(3):251-60. PubMed ID: 12802605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Blanco R; Carmona M; Ribera R; Goutan E; Puig B; Rey MJ; Cardozo A; Viñals F; Ribalta T
    Brain Pathol; 2001 Apr; 11(2):144-58. PubMed ID: 11303790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case manifested overlapping neuropathologic features of both progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD)].
    Inagaki T; Seno HI; Iijima M; Nagai A; Bokura H; Kobayashi S; Wada M; Harada T
    No To Shinkei; 1998 Mar; 50(3):263-71. PubMed ID: 9566003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy.
    Tuite PJ; Clark HB; Bergeron C; Bower M; St George-Hyslop P; Mateva V; Anderson J; Knopman DS
    Arch Neurol; 2005 Sep; 62(9):1453-7. PubMed ID: 16157754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticobasal degeneration: an autopsy case clinically diagnosed as progressive supranuclear palsy.
    Shiozawa M; Fukutani Y; Sasaki K; Isaki K; Hamano T; Hirayama M; Imamura K; Mukai M; Arai N; Cairns NJ
    Clin Neuropathol; 2000; 19(4):192-9. PubMed ID: 10919351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.